Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2021-01-04 8:21 pm |
N/A 2030-12-23 |
Trillium Therapeutics Inc. | TRIL | BESHAR LUKE M Director |
0 | $0 | 594,322 (Direct) |
View |
Ownership |
2021-01-04 8:21 pm |
N/A 2030-12-23 |
Trillium Therapeutics Inc. | TRIL | Parsons James T. Chief Financial Officer |
0 | $0 | 469,890 (Direct) |
View |
Ownership |
2021-01-04 8:20 pm |
N/A 2030-12-23 |
Trillium Therapeutics Inc. | TRIL | Reynolds Thomas C Director |
0 | $0 | 643,532 (Direct) |
View |
Ownership |
2021-01-04 8:19 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Harrison Rosemary See Remarks |
0 | $0 | 180,075 (Direct) |
View |
Ownership |
2021-01-04 8:19 pm |
N/A 2030-12-23 |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
0 | $0 | 509,263 (Direct) |
View |
Ownership |
2021-01-04 8:16 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Walker Paul Edward Director |
0 | $0 | 18,776,363 (Indirect) |
View |
Ownership |
2021-01-04 8:13 pm |
N/A 2030-12-23 |
Trillium Therapeutics Inc. | TRIL | KIRKMAN ROBERT L Director |
0 | $0 | 519,290 (Direct) |
View |
Ownership |
2021-01-04 8:12 pm |
N/A 2030-12-23 |
Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer |
0 | $0 | 339,086 (Direct) |
View |
Ownership |
2021-01-04 8:11 pm |
N/A 2030-09-17 |
Trillium Therapeutics Inc. | TRIL | Kamarck Michael E. Director |
0 | $0 | 67,000 (Direct) |
View |
Ownership |
2021-01-04 8:11 pm |
N/A 2030-12-23 |
Trillium Therapeutics Inc. | TRIL | Skvarka Jan President and CEO |
0 | $0 | 2,115,000 (Direct) |
View |
Ownership |
2021-01-04 8:09 pm |
N/A 2030-11-12 |
Trillium Therapeutics Inc. | TRIL | Bruns Ingmar Chief Medical Officer |
0 | $0 | 400,000 (Direct) |
View |
Ownership |
2021-01-04 8:08 pm |
N/A 2030-12-23 |
Trillium Therapeutics Inc. | TRIL | TAYTON-MARTIN HELEN KATRINA Director |
0 | $0 | 538,294 (Direct) |
View |